Found 65 matching trials
Bioequivalence Study of Sitagliptin/Metformin Extended-Release Tablets in Healthy Subjects PHASE1 The main purpose of this study is to compare the pharmacokinetics (how the ...
Show More Location
The Affiliated Hospital of Qingdao University
Learn More & Join Trial
Study in Healthy Subjects to Measure Amount of Drug in Blood After Dosing With Different Saxagliptin / Metformin Produc PHASE1 Study in healthy subjects to measure amount of drug in blood after dosing w...
Show More Learn More & Join Trial
Metformin Extended Release Versus Metformin Immediate Release in Subjects With Type 2 Diabetes PHASE4 This is a Phase 4, prospective, open label, randomized, parallel controlled...
Show More Location
Please contact the Merck KGaA Communication Center
Learn More & Join Trial
Prospective Trial of Metformin - Chemoprevention Role NA The goal of this clinical research study is to learn if metformin extended ...
Show More Location
Multiple Locations
Learn More & Join Trial
Crossover Study to Evaluate the Comparative Bioavailability of Two Fixed Dose Combination Tablet Formulations of Extended Release Metformin and Extended Release Glimepiride in Health Volunteers PHASE1 This is a an open-label, randomized, single dose, four-way crossover, multi...
Show More Location
GSK Investigational Site
Treatments Being Tested
Metformin, 500 mg extended release tablet Metformin, 1000 mg extended release tablet Glimepiride, 1 mg immediate release tablet Glimepiride, 2 mg immediate release tablet Metformin, 500 mg and Glimepiride, 1 mg extended release film coated tablet containing release controlling polymers Metformin, 1000 mg and Glimepiride, 2 mg extended release film coated tablet containing release controlling polymers Metformin, 500 mg and Glimepiride, 1 mg extended release tablet coated with release controlling polymers Metformin, 1000 mg and Glimepiride, 2 mg extended release tablet coated with release controlling polymers Learn More & Join Trial
A Study of Prusogliptin Tablets Combined With Dapagliflozin Tablets and Metformin Hydrochloride Extended Release Tablets in Type 2 Diabetes PHASE3 This study is a multicenter, randomized, double-blind, parallel-controlled,...
Show More Status
Active Not Recruiting
Location
No. 896, Zhongshan East Road, High-tech Industrial Development Zone
Treatments Being Tested
Prusogliptin, Dapagliflozin(high dose), Dapagliflozin (low dose) placebo, plus metformin XR Prusogliptin placebo, Dapagliflozin(high dose), Dapagliflozin (low dose) placebo, plus metformin XR Prusogliptin, Dapagliflozin(high dose) placebo, Dapagliflozin (low dose), plus metformin XR Prusogliptin placebo, Dapagliflozin (high dose) placebo, Dapagliflozin (low dose), plus metformin XR Prusogliptin, Dapagliflozin (high dose) placebo, Dapagliflozin(low dose) placebo, plus metformin XR Learn More & Join Trial
Study of Saxagliptin, 5-Hydroxy Saxagliptin, and Metformin Concentrations/Levels in Pediatric Subjects With T2DM PHASE1 The purpose of this study is to evaluate the pharmacokinetics of Saxaglipti...
Show More Location
Osborne Research Center
Learn More & Join Trial
Efficacy and Safety of Henagliflozin, Retagliptin, and Metformin Extended-Release Tablets in Chinese Patients With Type 2 Diabetes Mellitus N/A Given the significant and growing burden of Type 2 Diabetes (T2DM) in China...
Show More Location
Multiple Locations
Learn More & Join Trial
Effect of SCH 497079 on Metabolic Parameters and Influence of Race/Ethnic Origin on Therapeutic Response (Study P05338)(COMPLETED) PHASE1 The purpose of this study is to evaluate the effect of SCH 497079 on metabo...
Show More Location
Multiple Locations
Learn More & Join Trial
Antecedent Metabolic Health and Metformin Aging Study PHASE3 Aging is the number one risk factor for the majority of chronic diseases. T...
Show More Location
University of Oklahoma Health Sciences Center, Oklahoma Shared Clinical and Translational Resources
Learn More & Join Trial